
0:00
28:32
Dr. Sam Sanders, internist at Bellevue Hospital in NYC, takes us through a case-based review of metabolic dysfunction–associated steatotic liver disease (MASLD), an increasingly common condition. We cover updated terminology, risk stratification using FIB-4 scoring and FibroScans, indications for hepatology referral, and new management strategies to prevent fibrosis progression and cirrhosis.
Advertising Inquiries: https://redcircle.com/brands
Weitere Episoden von „Run the List“



Verpasse keine Episode von “Run the List” und abonniere ihn in der kostenlosen GetPodcast App.








